SGFG
NUTX

Silver Grove Financial Group’s Nutex Health NUTX Stock Holding History

Silver Grove Financial Group’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$854 Buy
+5
New +$634 ﹤0.01% 1902

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Silver Grove Financial Group's NUTX Position: Q2 2026 in Review

Silver Grove Financial Group opened a new position in Nutex Health (NUTX) in Q2 2026: 5 shares worth $854. The stake represents ﹤0.01% of the portfolio and ranks #1902 among its holdings.

154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Silver Grove Financial Group held 5 shares of Nutex Health worth $854 as of Q2 2026.
  • Nutex Health was a new Silver Grove Financial Group position in Q2 2026.
  • Nutex Health made up ﹤0.01% of Silver Grove Financial Group's portfolio in Q2 2026, its #1902 holding.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Silver Grove Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.